Your prediction
Biofrontera AG Stock
Heavy losses for Biofrontera AG today as the stock fell by -€0.140 (-5.150%).
Pros and Cons of Biofrontera AG in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Biofrontera Q2 Revenue Jumps 15%
Biofrontera(NASDAQ:BFRI) reported fiscal second quarter results for the period ended June 30, 2025, with total revenues rising to $9 million from $7.8 million a year earlier, representing a 15%
Biofrontera Revenue Jumps 15% in Q2
Biofrontera (NASDAQ:BFRI), a specialty biopharmaceutical company focused on dermatology solutions, released its financial results for the second quarter of fiscal 2025 on August 13, 2025. The